Table 3.
Baseline differences on primary outcomes and intervention targets between participants retained to T3 and those lost to follow-up
| M (SD) | Statistic | ||
|---|---|---|---|
| Retained (n = 155) | Lost to follow-up before T3 (n = 37) | ||
| FACT-G PWB | 23.62 (4.64) | 21.25 (5.15) | t(190) = − 2.73** |
| FACT-G SWB | 20.77 (4.50) | 20.05 (4.95) | t(190) = − 0.86 |
| FACT-G EWB | 20.65 (3.84) | 18.47 (5.24) | t(190) = − 2.88** |
| FACT-G FWB | 20.78 (4.71) | 18.61 (5.94) | t(190) = − 2.39** |
| EPIC urinary bother | 75.53 (17.91) | 73.02 (17.65) | t(189) = − 0.79 |
| EPIC urinary function | 81.83 (18.46) | 81.94 (15.81) | t(183) = 0.03 |
| EPIC sexual bother | 55.51 (39.21) | 54.46 (38.37) | t(176) = − 0.14 |
| EPIC sexual function | 11.89 (17.36) | 14.79 (19.40) | t(180) = 0.87 |
| PROMIS depression | 45.62 (8.30) | 49.93 (8.33) | t(188) = 2.83** |
| FSI | 7.67 (10.34) | 14.71 (18.60) | t(41) = 2.22* |
| MPQ | 5.15 (6.68) | 8.69 (9.63) | t(45) = 2.12* |
| MAX-PC total | 10.18 (9.62) | 16.09 (14.11) | t(38) = 2.26* |
| MAX-PC anxiety | 5.71 (7.24) | 9.56 (9.42) | t(47) = 2.32* |
| MAX-PC PSA | 0.63 (1.27) | 1.22 (1.99) | t(43) = 1.71 |
| MAX-PC fear | 3.85 (2.67) | 5.06 (3.43) | t(173) = 2.19* |
| IES-R total | 10.69 (11.40) | 16.73 (14.64) | t(190) = 2.73** |
| IES-R intrusions | 0.49 (0.59) | 0.72 (0.73) | t(190) = 1.99* |
| IES-R avoidance | 0.61 (0.68) | 0.90 (0.75) | t(190) = 2.30* |
| IES-R hyperarousal | 0.32 (0.47) | 0.64 (0.82) | t(42) = 2.27* |
| MOCS A relaxation | 0.84 (1.06) | 1.39 (1.31) | t(43) = 2.25* |
| MOCS A assertiveness | 2.70 (1.03) | 2.65 (1.21) | t(186) = − 0.26 |
| MOCS A awareness | 2.06 (1.17) | 2.22 (1.23) | t(171) = 0.69 |
| MOCS B cared for | 4.27 (0.78) | 4.44 (0.59) | t(188) = 1.27 |
| MOCS B downward | 4.44 (0.76) | 4.43 (0.88) | t(188) = − 0.03 |
| MOCS B bonding | 4.02 (0.99) | 4.43 (0.85) | t(188) = 2.30* |
| PSS total | 16.24 (6.97) | 19.49 (8.06) | t(187) = 2.42* |
| ABS | 79.93 (10.61) | 75.97 (12.07) | t(189) = −1.96 |
| SIP | 0.16 (0.22) | 0.27 (0.27) | t(45) = 2.21* |
*
p < 0.05
**
p < 0.01
FACT, Functional Assessment of Cancer Therapy; PWB, physical well-being; SWB, social well-being; EWB, emotional well-being; FWB, functional well-being; EPIC, Expanded Prostate Cancer Index; PROMIS, Patient-Reported Outcomes Measurement Information System; FSI, Fatigue Symptom Inventory; MPQ, McGill Pain Questionnaire, MAX-PC, Memorial Anxiety Scale for Prostate Cancer; IES-R, Impact of Events Scale – Revised; MOCS, Measure of Current States; PSS, Perceived Stress Scale; ABS, Affect Balance Scale; SIP, Sickness Impact Profile